CONDITION

Transitional Cell Carcinoma

Transitional cell carcinoma is the most common bladder cancer in dogs, arising from the cells lining the urinary tract, typically occurring in older dogs and causing urinary signs that can initially resemble infection or other bladder conditions.

Why this matters now

Transitional cell carcinoma predominantly affects older dogs, typically over nine years of age. Scottish Terriers have a dramatically increased risk—estimated at 18-20 times higher than other breeds. Shetland Sheepdogs, West Highland White Terriers, Beagles, and Wire Fox Terriers also show breed predisposition. Females are affected more often than males.

The tumour typically develops in the bladder wall, often at the trigone—the area where the ureters enter and the urethra exits. As it grows, the tumour invades the bladder wall and may obstruct urine flow. Local spread to nearby lymph nodes is common, and metastasis to distant sites including lungs and bones can occur as the disease progresses.

Signals & patterns

Early signals

Blood in the urine

Pink, red, or brown discolouration of urine, which may be intermittent initially.

Frequent urination attempts

Straining to urinate or making frequent trips to urinate with small volumes produced.

Apparent urinary infections that recur

Signs that improve temporarily with antibiotics but return, or fail to fully resolve.

Urinary accidents

Previously house-trained dogs may have accidents due to urgency or discomfort.

Later signals

Difficulty urinating

Straining with minimal urine production as the tumour obstructs the outflow.

Complete urinary obstruction

Inability to urinate despite repeated attempts, representing a significant complication.

Weight loss

Progressive weight loss as the cancer advances and affects overall health.

Hind limb weakness or lameness

May occur if the tumour spreads to the spine or pelvis, affecting nerves or bones.

Click to read about the biological mechanisms

How this is usually investigated

Assessment aims to confirm the diagnosis, determine the extent of the tumour, and evaluate for spread to other organs, informing discussions about management options and prognosis.

Urinalysis

Purpose: Identifies blood, abnormal cells, and concurrent infection in the urine
Considerations: Often shows blood and inflammation; cancer cells sometimes visible; infection may coexist.

Urine cytology

Purpose: Microscopic examination of urine sediment for cancer cells
Considerations: Can identify characteristic cells; negative result does not rule out cancer; transitional cells can appear abnormal with inflammation.

Abdominal ultrasound

Purpose: Visualises the bladder mass and assesses other abdominal organs and lymph nodes
Considerations: Non-invasive; shows mass location and size; evaluates for local spread; guides sampling.

BRAF mutation test

Purpose: Urine DNA test that detects a mutation present in most canine TCC cases
Considerations: Non-invasive; highly specific when positive; false negatives possible; supports diagnosis without biopsy.

Cystoscopy

Purpose: Direct visualisation of the bladder interior with camera, allowing biopsy
Considerations: Requires anaesthesia; provides tissue diagnosis; evaluates extent within bladder; therapeutic options possible.

CT scan

Purpose: Detailed imaging of the tumour extent and assessment for metastasis
Considerations: Requires anaesthesia; evaluates lymph nodes and distant spread; important for staging and planning.

Chest radiographs

Purpose: Screens for lung metastasis
Considerations: Part of staging workup; visible metastases affect prognosis and management decisions.

Options & trade-offs

Management depends on tumour location, extent of disease, and overall health, with various approaches aimed at controlling tumour growth, maintaining urinary function, and supporting quality of life.

Non-steroidal anti-inflammatory drugs

COX-inhibiting medications that may have direct anti-tumour effects

Trade-offs: Can slow progression; well tolerated by most dogs; foundation of many treatment protocols; gastrointestinal side effects possible.

Chemotherapy

Drugs to slow tumour growth and control disease spread

Trade-offs: Can provide meaningful disease control; side effects generally manageable; various protocols available; requires monitoring.

Metronomic chemotherapy

Low-dose, continuous oral chemotherapy combined with NSAIDs

Trade-offs: Convenient home administration; fewer side effects than conventional dosing; sustained disease control possible.

Surgery

Removal of the tumour when location permits

Trade-offs: Rarely curative due to typical trigone location; may help selected cases; specialist surgical techniques expanding options.

Urethral stent placement

Metal mesh tube placed to relieve urinary obstruction

Trade-offs: Restores urination when tumour blocks outflow; does not treat the cancer; complications possible; maintains quality of life.

Radiation therapy

Targeted radiation to control local tumour growth

Trade-offs: May help control local disease; requires specialist facilities; can cause urinary side effects; palliative benefit possible.

Palliative care

Focus on comfort and quality of life as priority

Trade-offs: Appropriate when other treatments not suitable; emphasises comfort over disease control; supports dignified remaining time.

Common misconceptions

Misconception:

"Blood in the urine in older dogs is always just a urinary tract infection"

Reality:

While infections are common, persistent or recurrent bloody urine in older dogs, especially predisposed breeds, warrants investigation for underlying bladder tumours.

Misconception:

"Bladder cancer means only days to weeks of survival"

Reality:

With appropriate treatment, many dogs with transitional cell carcinoma live comfortably for months, and some survive a year or longer.

Misconception:

"Nothing can be done for dogs with bladder cancer"

Reality:

Multiple treatment options can provide disease control and maintain quality of life; palliative approaches support comfort when curative intent is not possible.

Owners of older dogs experiencing urinary problems, particularly those with breeds at higher risk, may recognise the value of thorough investigation when signs persist or recur. Understanding that bladder cancer, while serious, can often be managed to maintain quality of life helps frame realistic expectations and supports informed discussions about care.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS